Loop | Georgios Georgountzos
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Οδοντιατρείο Ιωάννης Ζερδές - Home | Facebook
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
PDF) PD-1 protein and gene expression as prognostic factors in early breast cancer
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis Zerdes - Glifádha, Attiki, Greece | Professional Profile | LinkedIn
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Jonas Bergh's Group | Karolinska Institutet
